Daniel Morgenstern - Publications

University of Cambridge, Cambridge, England, United Kingdom 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW. Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro. Molecular and Cellular Neurosciences. 29: 82-96. PMID 15866049 DOI: 10.1016/j.mcn.2005.02.001  0.52
2003 Morgenstern DA, Asher RA, Naidu M, Carlstedt T, Levine JM, Fawcett JW. Expression and glycanation of the NG2 proteoglycan in developing, adult, and damaged peripheral nerve. Molecular and Cellular Neurosciences. 24: 787-802. PMID 14664826 DOI: 10.1016/S1044-7431(03)00245-8  0.52
2002 Morgenstern DA, Asher RA, Fawcett JW. Chondroitin sulphate proteoglycans in the CNS injury response Progress in Brain Research. 137: 313-332. PMID 12440375 DOI: 10.1016/S0079-6123(02)37024-9  0.52
2002 Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2225-36. PMID 11896162  0.52
Show low-probability matches.